ArticleNutrients2024

Global Leadership Initiative on Malnutrition Criteria and Immunonutritional Status Predict Chemoadherence and Survival in Stage II/III Gastric Cancer Treated with XELOX Chemotherapy.

Jong Hyuk Yun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.